Abnormal hippocampal distribution of TDP-43 in patients with-late onset psychosis

Australian and New Zealand Journal of Psychiatry

Volumn 43, Issue 8, 2009, Pages 739-745

  Velakoulis, Dennis ^a,b   Walterfang, Mark ^a,b   Mocellin, Ramon ^a,b   Pantelis, Christos ^b   Dean, Brian ^c   McLean, Catriona ^b,d  

^a ROYAL MELBOURNE HOSPITAL   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

^c FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^d ALFRED HOSPITAL   (Australia)

Author keywords

Frontotemporal dementia; Late onset psychosis; Neuropathology; Schizophrenia; TDP 43; Ubiquitin

Indexed keywords

TAR DNA BINDING PROTEIN; UBIQUITIN;

ADULT; AGED; ARTICLE; AUSTRALIA; BEHAVIOR CHANGE; BIPOLAR DISORDER; BRAIN WEIGHT; CLINICAL ARTICLE; COMPULSION; CONTROLLED STUDY; DENTATE GYRUS; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; NEUROPATHOLOGY; NEUROPSYCHIATRY; ONSET AGE; PERSONALITY DISORDER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PSYCHOSIS; SCHIZOPHRENIA;

ADULT; AGE OF ONSET; AGED; BIPOLAR DISORDER; CADAVER; CASE-CONTROL STUDIES; DENTATE GYRUS; DNA-BINDING PROTEINS; FAMILY HEALTH; FEMALE; HUMANS; MALE; MIDDLE AGED; NERVE DEGENERATION; SCHIZOPHRENIA; UBIQUITIN;

EID: 68549118968     PISSN: 00048674     EISSN: 14401614     Source Type: Journal    
DOI: 10.1080/00048670903001984     Document Type: Article

References (22)

1. McKhann GM, Albert MS, Grossman M, Miller B, Dickson D, Trojanowski JQ. Clinical and pathological diagnosis of frontotemporal dementia: Report of the Work Group on Frontotemporal Dementia and Pick's Disease. Arch Neurol 2001; 58:1803-1809.
2. Cairns NJ, Bigio EH, Mackenzie IRA et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the Consortium for Frontotemporal Lobar Degeneration. Acta Neuropathol 2007; 114:5-22.
3. Hutton M, Lendon CL, Rizzu P et al. Association of missense and 5'-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 1998; 393(6686):702-705.
4. Neumann M, Sampathu DM, Kwong L et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 2006; 314(5796):130- 133.
5. Cairns NJ, Neumann M, Bigio EH et al. TDP-43 in familial and sporadic frontotemporal lobar degeneration with ubiquitin inclusions. Am J Pathol 2007; 171:227-240.
6. Forman MS, Trojanowski JQ, Lee VMY. TDP-43: A novel neurodegenerative proteinopathy. Curr Opin Neurobiol 2007; 17:548-555.
7. Velakoulis D, Walterfang M, Mocellin R, Pantelis C, McLean CA. Frontotemporal dementia presenting as schizophrenialike psychosis in young subjects: Clinicopathological series and review of 751 cases. Br J Psychiatry 2009; 194:298-305.
8. Mackenzie IRA, Rademakers R. The molecular genetics and neuropathology of frontotemporal lobar degeneration: Recent developments. Neurogenetics 2007; 8:237-248.
9. Mateen FJ, Josephs K. TDP-43 is not present in brain tissue of patients with schizophrenia. Schizophr Res 2008; 108:297- 298.
10. Horton K, Forsyth CS, Sibtain N et al. Ubiquitination as a probe for neurodegeneration in the brain in schizophrenia: The prefrontal cortex. Psychiatry Res 1993; 48:145-152.
11. American Psychiatric Association. Diagnostic criteria for DSM-IV. Washington, DC: American Psychiatric Association, 1994.
12. Hill C, Keks N, Roberts S et al. Problem of diagnosis in postmortem brain studies of schizophrenia. Am J Psychiatry 1996; 153:533-537.
13. Kingsbury AE, Foster OJ, Nisbet AP et al. Tissue pH as an indicator of mRNA preservation in human post-mortem brain. Brain Res Mol Brain Res 1995; 28:311-318.
14. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The Stanley Foundation brain collection and neuropathology consortium. Schizophr Res 2000; 44:151-155.
15. Strong MJ, Volkening K, Hammond R et al. TDP43 is a human low molecular weight neurofilament (hNFL)mRNAbinding protein. Mol Cell Neurosci 2007; 35:320-327.
16. Wang IF, Wu L-S, Chang H-Y, Shen CKJ. TDP-43, the signature protein of FTLD-U, is a neuronal activityresponsive factor. J Neurochem 2008; 105:797-806.
17. Harrison PJ. The neuropathology of schizophrenia: A critical review of the data and their interpretation. Brain 1999; 122:593-624.
18. Casanova MF, Stevens JR, Brown R, Royston C, Bruton C. Disentangling the pathology of schizophrenia and paraphrenia. Acta Neuropathol (Berl) 2002; 103:313-320.
19. Dickson D. Neurodegeneration. The molecular pathology of dementia and movement disorders. Basel: ISN Neuropath Press, 2003.
20. Lichtenstein P, Yip B, Björk C et al. Common genetic determinants of schizophrenia and bipolar disorder in Swedish families: a population-based study. Lancet 2009; 373:234-239.
21. Howard R, Castle D, Wessely S, Murray R. A comparative study of 470 cases of early-onset and late-onset schizophrenia. Br J Psychiatry 1993; 163:352-357.
22. Castle DJ, Wessely S, Howard R, Murray RM. Schizophrenia with onset at the extremes of adult life. Int J Geriatr Psychiatry 1997; 12:712-717.